Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px
Document › Details

Bone Therapeutics S.A.. (3/7/18). "Press Release: Bone Therapeutics Announces Private Placement of Convertible Bonds [Not for the United States, Australia, Canada, Japan, South Africa, et al.]". Gosselies.

Organisations Organisation Bone Therapeutics S.A. (Euronext Brussels + Paris: BOTHE)
  Group Bone Therapeutics (Group)
  Organisation 2 NewCap. – Investor Relations & Financial Communications
Products Product ALLOB® allogeneic bone cell product
  Product 2 investment banking
Persons Person Lienard, Thomas (Bone Therapeutics 201610– Interim CEO joined 201511– as CBO before Lundbeck + Lilly + McKinsey)
  Person 2 Fennell, Amber (Bielecka, Amber) (Consilium Strategic Communications 201307– Co-founder)
     


   
Record changed: 2018-03-22

Advertisement

Picture [iito] – Putting Information into Context 600x102px

More documents for Bone Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px




» top